BYOMass Company

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.


Investors

Total Funding: 1500000
Headquarters: Sudbury, Massachusetts, United States
Employee Number: 1-10
Last Funding Type: Venture - Series Unknown
Number Of Exists: Venture - Series Unknown
Technology: Geroscience
Investor Type: Company
Last Funding Date: 2019
Investors Number: 1
Founded Date: 2017
Industry: Biotechnology